StocksRunner logo
 
 
 
 
»
 

Wall Street Trading Week Begins: Navigating the Season of Reports and Inflation

 
 
 
 

stocks on the run

 
 
 

Tomorrow marks the start of a new trading week on Wall Street, with the publication of the consumer price index data on Wednesday and the commencement of the first quarter report season on Friday. It is customary for leading banks to present their reports during this time.

 

The consumer price index is widely regarded as the most crucial market indicator for assessing the economy's status and projecting the Fed's interest rate hikes. Despite a slight drop from the peak of 9.1%, inflation is still sticky and currently at 6% after a 0.4% increase in February. Although the central bank has set a target of 2%, achieving it seems a distant prospect. Predictions from Wall Street suggest that inflation will rise by 0.3% in March, putting the annual figure at 5.2%. While this is a relatively optimistic figure, it is not beyond reach. As the numbers decrease, achieving further reductions becomes increasingly challenging. Should the predictions prove accurate, it is not unlikely for Wall Street indices to register gains for several days.

 
Week
 

Despite the optimistic inflation figures, there is an overarching concern stemming from the dire warnings issued by senior economists about an impending recession. The Fed has taken a firm stance on curbing inflation, even at the risk of entering a recession. The central bank has reiterated its commitment to take all possible measures to combat inflation, as it is deemed more perilous than a recession. Inflation has the potential to cripple the economy and inflict irreversible damage over time, as per the Fed's assessment.

 

The upcoming report season is a significant event set to kick off with bank reports, following two challenging months for the banking sector. The troubles began with the collapse of Silicon Valley Bank (SVB), which had a domino effect on other banks such as Signature and First Republic. The regional banks' stocks plummeted by a substantial percentage, causing a momentary dent in big banks' confidence. This makes the start of the report season particularly noteworthy.

 
Week
 

In response to the collapse of several banks, President Biden announced a rescue plan in collaboration with the Fed to prevent the industry from spiraling further downward. However, despite the injection of cash and reassuring statements, the efforts did not seem to have a significant impact. Investors started to sense that this was the beginning of the anticipated recession, and the stocks continued to plummet. Currently, there appears to be a pause in the market turbulence.

 

The CEO of JP Morgan, Jamie Dimon, cautioned last week that those who believed the recession was over should reconsider their stance.

 

"Even when this crisis is behind us, it will have ramifications for years to come," Dimon told the investment bank's shareholders. But more importantly, recent events are nothing like what happened during the global financial crisis of 2008," he added.

 
 

stocks on the run

 
 
 
unlock
 
 
 

Please note that the article should not be considered as investment advice or marketing, and it does not take into account the personal data and requirements of any individual. It is not a substitute for the reader's own judgment, and it should not be considered as advice or recommendation for buying or selling any securities or financial products.

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our Daily Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner

StocksRunner

Get the pulse of the market

 
 
 
StocksRunner

Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our Daily Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.